The name rVSV-ZEBOV may not mean much at the moment, but those letters could be lifesaving in a few months.
That’s because the rVSV-ZEBOV vaccine is the world’s first for Ebola. The immunization proved 100 percent effective in testing and could be licensed for sale by the end of this year.
Many are excited about this breakthrough. The prospect of eradicating Ebola is a dream come true, especially after the worldwide outbreak in 2014.
But, it might be too early to start planning your end-of-Ebola party. In fact, current plans and critics of the vaccine show that it might not spell an immediate end for the virus.